ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 38530 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 38530; 2) Community: the network communities that were significantly associated with the response to NSC 38530; 3) Molecule: the relationships between components within communities and NSC 38530; 4) MDR: the compounds that were significantly associated with the NSC 38530.

NSC Compound Enrichment Correlation
NSC 135073 WITHACNISTIN 0.0478540623811426 0.6280347
NSC 165572 Pyrido[3,2-g]quinoline-2,5,8,10(1H,9H)-tetrone, 1,4,6-trimethyl- 0.0478540623811426 -0.0057941815
NSC 168516 Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- 0.0478540623811426 0.16179656
NSC 292816 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) 0.0478540623811426 0.044051669
NSC 295499 Camptothecin Derivative 0.0478540623811426 0.0090703018
NSC 330507 Tanespimycin 0.0478540623811426 0.081470936
NSC 350629 2-Propen-1-one, 2-[(dimethylamino)methy]-1-(4- .beta.-D-glucopyranosyloxyphenyl)-, tetraacetate ester 0.0478540623811426 0.8158419
NSC 408171 Null 0.0478540623811426 -0.29884321
NSC 603084 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- 0.0478540623811426 0.64917934
NSC 616960 2[5H]-Furanone, 5-[(.beta.-D-glucopyranosyloxy)methyl]-,(S)- (9CI) 0.0478540623811426 0.46729368
Total:84  Current:77    [First] [Prev] [Next] [Last]